Consistently, we observed high expression of CX3CL1 in an independent collection of NPC tumours (n = 113) compared to non-cancerous samples (rhinitis, n = 10; Supplementary Fig. 10b). This evidence concerns the gene CX3CL1 and nasopharyngeal carcinoma.